⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL14660103 | 0.95 | KDM4E (0.42) | — | |
| SCHEMBL23660865 | 0.88 | — | — | |
| SCHEMBL15424796 | 0.82 | — | — | |
| SCHEMBL24554233 | 0.82 | — | — | |
| SCHEMBL9273407 | 0.79 | EPHX1 (0.40) | — | |
| SCHEMBL27120 | 0.79 | — | — | |
| SCHEMBL8002040 | 0.76 | — | — | |
| SCHEMBL1289798 | 0.76 | — | — | |
| Bromide SCHEMBL27323221 | 0.76 | — | — | |
| SCHEMBL18731586 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025045758-A1 | ANTIBODY-DRUG CONJUGATES BASED ON MOLECULAR GLUE DEGRADERS AND USES THEREOF | MABLINK BIOSCIENCE (FR) | 2025-03-06 | — | — | WO | disclosed |
| WO-2025045761-A1 | MOLECULAR GLUE DEGRADERS AND USES THEREOF | MABLINK BIOSCIENCE (FR) | 2025-03-06 | — | — | WO | disclosed |
| EP-4512427-A1 | ANTIBODY-DRUG CONJUGATES BASED ON MOLECULAR GLUE DEGRADERS AND USES THEREOF | Mablink Bioscience (FR) | 2025-02-26 | — | — | EP | disclosed |
| EP-4512806-A1 | MOLECULAR GLUE DEGRADERS AND USES THEREOF | Mablink Bioscience (FR) | 2025-02-26 | — | — | EP | disclosed |
| EP-3798117-A1 | REINFORCED SUPERPLASTIC FORMED AND DIFFUSION BONDED STRUCTURES | The Boeing Company (US) | 2021-03-31 | — | — | EP | disclosed |
| WO-2017165822-A1 | SMALL MOLECULE INHIBITOR OF THE NUCLEAR TRANSLOCATION OF ANDROGEN RECEPTOR FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2017-09-28 | — | — | WO | disclosed |
| US-20130157964-A1 | Blockade Of Inflammatory Proteases With Cyclic Peptides | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-06-20 | — | — | US | disclosed |
| EP-1322641-B1 | PHARMACEUTICALLY ACTIVE HYDROPHILIC SULFONAMIDE DERIVATIVES AS INHIBITORS OF PROTEIN JUNKINASES | MERCK SERONO SA (CH) | 2012-07-25 | — | — | EP | disclosed |
| US-20040077632-A1 | Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases | MERCK SERONO SA (CH) | 2004-04-22 | — | — | US | disclosed |
| EP-1322641-A1 | PHARMACEUTICALLY ACTIVE HYDROPHILIC SULFONAMIDE DERIVATIVES AS INHIBITORS OF PROTEIN JUNKINASES | Applied Research Systems ARS Holding N.V. (AN) | 2003-07-02 | — | — | EP | disclosed |
| WO-2002028856-A1 | PHARMACEUTICALLY ACTIVE HYDROPHILIC SULFONAMIDE DERIVATIVES AS INHIBITORS OF PROTEIN JUNKINASES | APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) | 2002-04-11 | — | — | WO | disclosed |
| EP-1193267-A1 | Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein JunKinases | Applied Research Systems ARS Holding N.V. (AN) | 2002-04-03 | — | — | EP | disclosed |
| EP-0619492-B1 | Determination of an analyte in a liquid sample | BOEHRINGER MANNHEIM GMBH (DE) | 1998-07-01 | — | — | EP | disclosed |
| US-5397711-A | Determination of an analyte in a sample liquid | BOEHRINGER MANNHEIM GMBH (DE) | 1995-03-14 | — | — | US | disclosed |
| EP-0619492-A1 | Determination of an analyte in a liquid sample | Roche Diagnostics GmbH (DE) | 1994-10-12 | — | — | EP | disclosed |
| EP-0132678-A1 | Copolymers of methyl esters of N-vinyl-carbamic acid | BAYER AG (DE) | 1985-02-13 | — | — | EP | disclosed |